PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis
Public ClinicalTrials.gov record NCT02073409. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Isolation of nontuberculous mycobacteria (NTM) from the sputum of individuals with CF is an increasingly common finding, and the lack of an evidenced-based approach to the diagnosis of NTM disease has been identified as one of the greatest unmet needs within the CF community. Current evidence predicts that the prevalence of NTM will remain relatively high in the CF population. Approaches to NTM disease diagnosis differ widely between centers. This study is observational and follows current best practices. The study will help standardize the diagnosis and collect relevant data associated with the diagnosis of NTM disease to build a framework for future therapeutic trials.
Study identification
- NCT ID
- NCT02073409
- Recruitment status
- Not listed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 6 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2013 (Type not available)
- Primary completion
- Mar 2025 (Estimated)
- Completion
- Mar 2025 (Estimated)
- Last update posted
- Apr 2, 2024
2013 – 2025
United States locations
- U.S. sites
- 19
- U.S. states
- 16
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| CFF Pediatric Program, University of Alabama | Birmingham | Alabama | 35233 | — |
| Children's Hospital of Los Angeles | Los Angeles | California | — | — |
| University of California San Diego | San Diego | California | — | — |
| Children's Hospital Colorado | Aurora | Colorado | 80045 | — |
| National Jewish Health | Denver | Colorado | 80206 | — |
| University of Florida | Gainesville | Florida | — | — |
| Northwestern University | Chicago | Illinois | — | — |
| CFF Adult Program, Johns Hopkins University | Baltimore | Maryland | 21205 | — |
| Boston Children's Hospital, Brigham & Women's Hospital | Boston | Massachusetts | — | — |
| CFF Pediatric Program University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | — | — |
| CFF Pediatric Program, Columbia University | New York | New York | 10032 | — |
| CFF Adult Program, University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27517 | — |
| Nationwide Children's Hospital | Columbus | Ohio | — | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | — | — |
| CFF Adult Program, The University of Texas Southwestern Medical Center at Dallas | Dallas | Texas | 75390-8558 | — |
| University of Vermont Medical Center | Burlington | Vermont | — | — |
| CFF Pediatric Program Seattle Children's Hospital | Seattle | Washington | 98105 | — |
| CFF Adult Program, University of Washington | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02073409, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 2, 2024 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02073409 live on ClinicalTrials.gov.